Epigenetic mechanisms of vascular dysfunction in obesity and type 2 diabetes
Author(s) -
Sarah Costantino
Publication year - 2019
Publication title -
cardiovascular medicine
Language(s) - English
Resource type - Journals
eISSN - 1664-204X
pISSN - 1664-2031
DOI - 10.4414/cvm.2019.02064
Subject(s) - epigenetics , epigenome , insulin resistance , type 2 diabetes , bioinformatics , dna methylation , context (archaeology) , diabetes mellitus , biology , obesity , epigenomics , medicine , disease , histone , genetics , endocrinology , gene , gene expression , paleontology
A careful assessment of the “epigenetic landscape” in cardiometabolic patients may contribute to the estimation of global cardiovascular risk, thus providing the tools for a personalised therapeutic approach. The present review describes the emerging role of epigenetics in the pathogenesis of cardiovascular complications in obesity and type 2 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom